CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Art Pappas will be on a panel at the UNC Alternative Investments Conference in Chapel Hill, NC.
News | 02. 16. 2011
© 2022 Pappas Capital, LLC. ALL RIGHTS RESERVED.